<DOC>
	<DOCNO>NCT01263821</DOCNO>
	<brief_summary>RATIONALE : New image technique use magnetic resonance image give good tumor definition , thus may lead good tumor target avoid damage critical part normal brain . PURPOSE : This phase I/II trial study well image-guided therapy work treat patient newly diagnose intracranial glioma .</brief_summary>
	<brief_title>Image Guided Therapy Treatment Gliomas</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To correlate imaging finding pathological grade follow surgery patient newly diagnose intra-cranial glioma . SECONDARY OBJECTIVES : I . To determine feasibility define optimal target volume radiation therapy use MR spectroscopy , diffusion , perfusion functional imaging . II . To monitor therapeutic response follow treatment use MR spectroscopy , diffusion image perfusion study . III . To monitor change neurocognitive functioning follow image guide therapy . OUTLINE : Patients undergo magnetic resonance spectroscopic imaging , functional magnetic resonance imaging ( MRI ) , diffusion-weighted MRI , perfusion-weighted MRI . Patients undergo maximum surgical resection follow intensity-modulated radiation therapy ( IMRT ) 5 day week 6 week . After completion study treatment , patient follow every 3 month first year every 6 month another year .</detailed_description>
	<mesh_term>Glioma</mesh_term>
	<criteria>Histologically confirm , newly diagnose intracranial glioma A diagnostic contrast enhance CT/MRI demonstrate lesion prior registration Karnofsky performance status &gt; = 60 Ability undergo MR imaging use Gadolinium dye Patient must sign study specific informed consent form ; patient 's mental status preclude his/her give inform consent , write informed consent may give patient 's legal representative Inability obtain histological proof glioma Allergy Gadolinium contrast Any condition include metallic implant cardiac pace maker make candidate ineligible MR image Any medical condition include renal cardiac insufficiency make candidate high risk gadolinium contrast administration Karnofsky performance status = &lt; 50 Prior history radiation therapy brain Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>glioma</keyword>
	<keyword>biologic imaging</keyword>
	<keyword>magnetic resonance spectroscopy</keyword>
	<keyword>magnetic resonance imaging</keyword>
	<keyword>perfusion image</keyword>
	<keyword>diffusion image</keyword>
	<keyword>functional magnetic resonance imaging</keyword>
	<keyword>radiation therapy</keyword>
	<keyword>intensity modulate radiation therapy</keyword>
</DOC>